tert-Butyl 4-(2-chloro-5-methylpyrimidin-4-yl)piperazine-1-carboxylate

Catalog No. :
ACGJQH982
CAS No. :
1538605-53-6
Molecular Formula :
C14H21ClN4O2
Molecular Weight :
312.80

IUPAC Name:tert-butyl 4-(2-chloro-5-methylpyrimidin-4-yl)piperazine-1-carboxylate

tert-Butyl 4-(2-chloro-5-methylpyrimidin-4-yl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$522.00Login to see priceInquiryInquiry
250mg95%$1040.00Login to see priceInquiryInquiry
1g95%$3119.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(2-chloro-5-methylpyrimidin-4-yl)piperazine-1-carboxylate
IUPAC Nametert-butyl 4-(2-chloro-5-methylpyrimidin-4-yl)piperazine-1-carboxylate
MDL No.MFCD28502966
Molecular FormulaC14H21ClN4O2
Molecular Weight312.80
SMILESO=C(N1CCN(C2=NC(Cl)=NC=C2C)CC1)OC(C)(C)C
InChI KeyGTOSQTHRZIIFOG-UHFFFAOYSA-N
Synonymtert-butyl 4-(2-chloro-5-methylpyrimidin-4-yl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-(2-chloro-5-methyl-4-pyrimidinyl)-, 1,1-dimethylethyl ester
CAS No.1538605-53-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACGJQH982 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGJQH982 route product structure diagram
    ACGJQH9821538605-53-6
Inquiry

2. ACGJQH982 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGJQH982 route product structure diagram
    ACGJQH9821538605-53-6
Inquiry

Comments (0)